Follow on Google News News By Tag * Healthcare * Pharma * Reform * Drug * Reimbursement * Regulatory * Risk-sharing * Generic * Improving * Law * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Now Available: Pharmaceutical Key Trends 2011New Healthcare research report from Datamonitor is now available from Fast Market Research
Features and benefits * An overview of healthcare expenditure in the 12 major markets * Insight into the major reforms of healthcare systems in the developed and developing markets * An assessment of the regulatory issues that are affecting global pharma markets. * Analysis of the key pricing and reimbursement controls that are affecting pharma ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Highlights As a result, healthcare reforms in EU and Japan focus on containing costs, without impacting quality of service. Ongoing measures include pricing and reimbursement cuts, bolstering generic usage, as well as other cost cutting tools, with the outcome largely negative for branded pharma. Although the US health reform law may well result in extended health insurance coverage and increase government involvement in healthcare, costs are expected to escalate. In the short-term though, discounts and rebates implemented as part of the reform are expected to result in drop in US sales. Reforms in the emerging markets concentrate on improving the quality and coverage of healthcare, providing opportunities for pharma, particularly for generics manufacturers. Nevertheless, as healthcare access expands and quality improves, funding pressures increase, leading to the introduction of cost-containment. Your key questions answered * Evaluate key factors driving healthcare expenditure as well as measures implemented by governments strategies implemented to contain further growth. * Gain insight into the impact of healthcare reforms in the developed and emerging markets and their impact on pharma. * Assess pharma's responses to the increasingly tough regulatory and reimbursement environment. Partial Table of Contents: Executive Summary Introduction Strategic scoping and focus Key findings Key growth drivers and resistors facing healthcare payers and pharma Healthcare expenditure Healthcare reforms Regulatory issues Pricing and reimbursement Related Reports Upcoming related reports HEALTHCARE EXPENDITURE Healthcare expenditure is growing fast There are several factors driving up healthcare expenditure across the markets analyzed: The proportion of public contribution to healthcare is greater in the developed as compared to the emerging markets However, despite improving economies, the emerging markets like the developed markets, are under pressure to contain costs, leading to implementation of strategies such as price cuts that are impacting pharma companies operating in such markets. Pharmaceutical expenditure is increasing in all markets HEALTHCARE REFORMS Healthcare reforms focus on improving access and cutting costs The main aim of healthcare reforms in the EU and Japan is to contain costs France is reforming hospital management to reduce costs Germany is transferring cost of healthcare onto individuals to rein in spending Italy has been engaged in a raft of healthcare reforms Spain's recent healthcare reforms have focused on pricing and reimbursement issues UK primary care trusts will be phased out An aging population has necessitated cost-containment measures in Japan Healthcare reforms in emerging markets will positively impact pharma Key aims of healthcare reforms in emerging markets include the following: India plans to expand healthcare services Healthcare continues to be a priority for Brazil's government Russia rolls out its 2020 healthcare plan China is making strides in improving health insurance coverage Healthcare reforms in the US will largely have a neutral impact on pharma Healthcare reform has already had an impact on pharma in Will the healthcare reform law be repealed? Potential impact of healthcare reform on pharmaceutical sales Healthcare systems globally are converging towards a similar model Closes payer-pharma relationships set to evolve Disease management will become central to payer decisions Pharma will need to manage both patient and payer expectations Several key markets are decentralizing healthcare decision-making to increase efficiency UK's decentralization strategy has raised concerns regarding inequality of access to healthcare services Italy has already devolved many powers to regions causing inequality in access to care and treatments Brazil, Russia, and China are also engaging in decentralization strategies REGULATORY ISSUES Regulatory changes have a largely negative impact on pharma Heightened safety concerns continue to impact pharma Collaboration between the FDA and EMA is intensifying EU ban on direct-to-patient communication guidelines partially relaxed Developed markets exhibit a stable intellectual property environment It is generally easier to secure patent protection in the US than in the EU The EU follows the 8+2+1 rule Japan gives branded pharma companies 8 years of data exclusivity through re-evaluation requirement Springboarding allows generics manufacturers to access branded drug data in Australia Full Table of Contents is available at: -- http://www.fastmr.com/ About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number